168 related articles for article (PubMed ID: 29730775)
1. DNA methylation-based reclassification of olfactory neuroblastoma.
Capper D; Engel NW; Stichel D; Lechner M; Glöss S; Schmid S; Koelsche C; Schrimpf D; Niesen J; Wefers AK; Jones DTW; Sill M; Weigert O; Ligon KL; Olar A; Koch A; Forster M; Moran S; Tirado OM; Sáinz-Jaspeado M; Mora J; Esteller M; Alonso J; Del Muro XG; Paulus W; Felsberg J; Reifenberger G; Glatzel M; Frank S; Monoranu CM; Lund VJ; von Deimling A; Pfister S; Buslei R; Ribbat-Idel J; Perner S; Gudziol V; Meinhardt M; Schüller U
Acta Neuropathol; 2018 Aug; 136(2):255-271. PubMed ID: 29730775
[TBL] [Abstract][Full Text] [Related]
2. IDH2 R172 Mutations Across Poorly Differentiated Sinonasal Tract Malignancies: Forty Molecularly Homogenous and Histologically Variable Cases With Favorable Outcome.
Glöss S; Jurmeister P; Thieme A; Schmid S; Cai WY; Serrette RN; Perner S; Ribbat-Idel J; Pagenstecher A; Bläker H; Keber U; Stadelmann C; Zechel S; Johann PD; Hasselblatt M; Paulus W; Thomas C; Dohmen H; Baumhoer D; Frank S; Agaimy A; Schüller U; Vasudevaraja V; Snuderl M; Liu CZ; Pfister DG; Jungbluth AA; Ghossein RA; Xu B; Capper D; Dogan S
Am J Surg Pathol; 2021 Sep; 45(9):1190-1204. PubMed ID: 34265800
[TBL] [Abstract][Full Text] [Related]
3. DNA methylation-based classification of sinonasal undifferentiated carcinoma.
Dogan S; Vasudevaraja V; Xu B; Serrano J; Ptashkin RN; Jung HJ; Chiang S; Jungbluth AA; Cohen MA; Ganly I; Berger MF; Momeni Boroujeni A; Ghossein RA; Ladanyi M; Chute DJ; Snuderl M
Mod Pathol; 2019 Oct; 32(10):1447-1459. PubMed ID: 31186531
[TBL] [Abstract][Full Text] [Related]
4. [Clinicopathologic study of sinonasal teratocarcinosarcoma and its contrast with olfactory neuroblastoma].
Li X; Liu HG; Xie XJ; Han YD; Li M
Zhonghua Bing Li Xue Za Zhi; 2008 Jul; 37(7):458-64. PubMed ID: 19035117
[TBL] [Abstract][Full Text] [Related]
5. Recurrent Wnt Pathway and ARID1A Alterations in Sinonasal Olfactory Carcinoma.
Rooper LM; Agaimy A; Bell D; Gagan J; Gallia GL; Jo VY; Lewis JS; London NR; Nishino M; Stoehr R; Thompson LDR; Din NU; Wenig BM; Westra WH; Bishop JA
Mod Pathol; 2024 Feb; 37(5):100448. PubMed ID: 38369189
[TBL] [Abstract][Full Text] [Related]
6. Clinicopathologic Features and Prognosis of Olfactory Neuroblastoma with Isocitrate Dehydrogenase 2 Mutations.
Wu L; An J; Liu H
World Neurosurg; 2022 Mar; 159():e23-e31. PubMed ID: 34856401
[TBL] [Abstract][Full Text] [Related]
7. Anaplastic astrocytoma with piloid features, a novel molecular class of IDH wildtype glioma with recurrent MAPK pathway, CDKN2A/B and ATRX alterations.
Reinhardt A; Stichel D; Schrimpf D; Sahm F; Korshunov A; Reuss DE; Koelsche C; Huang K; Wefers AK; Hovestadt V; Sill M; Gramatzki D; Felsberg J; Reifenberger G; Koch A; Thomale UW; Becker A; Hans VH; Prinz M; Staszewski O; Acker T; Dohmen H; Hartmann C; Mueller W; Tuffaha MSA; Paulus W; Heß K; Brokinkel B; Schittenhelm J; Monoranu CM; Kessler AF; Loehr M; Buslei R; Deckert M; Mawrin C; Kohlhof P; Hewer E; Olar A; Rodriguez FJ; Giannini C; NageswaraRao AA; Tabori U; Nunes NM; Weller M; Pohl U; Jaunmuktane Z; Brandner S; Unterberg A; Hänggi D; Platten M; Pfister SM; Wick W; Herold-Mende C; Jones DTW; von Deimling A; Capper D
Acta Neuropathol; 2018 Aug; 136(2):273-291. PubMed ID: 29564591
[TBL] [Abstract][Full Text] [Related]
8. Genome-wide methylation profiling identifies novel methylated genes in neuroblastoma tumors.
Olsson M; Beck S; Kogner P; Martinsson T; Carén H
Epigenetics; 2016; 11(1):74-84. PubMed ID: 26786290
[TBL] [Abstract][Full Text] [Related]
9. Calretinin staining facilitates differentiation of olfactory neuroblastoma from other small round blue cell tumors in the sinonasal tract.
Wooff JC; Weinreb I; Perez-Ordonez B; Magee JF; Bullock MJ
Am J Surg Pathol; 2011 Dec; 35(12):1786-93. PubMed ID: 22020045
[TBL] [Abstract][Full Text] [Related]
10. [Study on pathological features and diagnosis, differential diagnosis of olfactory neuroblastoma].
Liu HG; Zhang SZ; He CY
Zhonghua Bing Li Xue Za Zhi; 2003 Oct; 32(5):432-6. PubMed ID: 14633455
[TBL] [Abstract][Full Text] [Related]
11. Codeletion of 1p and 19q determines distinct gene methylation and expression profiles in IDH-mutated oligodendroglial tumors.
Mur P; Mollejo M; Ruano Y; de Lope ÁR; Fiaño C; García JF; Castresana JS; Hernández-Laín A; Rey JA; Meléndez B
Acta Neuropathol; 2013 Aug; 126(2):277-89. PubMed ID: 23689617
[TBL] [Abstract][Full Text] [Related]
12. Olfactory Neuroblastoma: Morphological Reappraisal and Molecular Insights with Quantum Leap in Clinical Perspectives.
Bell D; Brandea AI; Hanna EY
Curr Oncol Rep; 2023 Jan; 25(1):11-18. PubMed ID: 36449116
[TBL] [Abstract][Full Text] [Related]
13. Olfactory neuroblastoma is a peripheral primitive neuroectodermal tumor related to Ewing sarcoma.
Sorensen PH; Wu JK; Berean KW; Lim JF; Donn W; Frierson HF; Reynolds CP; López-Terrada D; Triche TJ
Proc Natl Acad Sci U S A; 1996 Feb; 93(3):1038-43. PubMed ID: 8577710
[TBL] [Abstract][Full Text] [Related]
14. Frequent IDH2 R172 mutations in undifferentiated and poorly-differentiated sinonasal carcinomas.
Dogan S; Chute DJ; Xu B; Ptashkin RN; Chandramohan R; Casanova-Murphy J; Nafa K; Bishop JA; Chiosea SI; Stelow EB; Ganly I; Pfister DG; Katabi N; Ghossein RA; Berger MF
J Pathol; 2017 Aug; 242(4):400-408. PubMed ID: 28493366
[TBL] [Abstract][Full Text] [Related]
15. Immunohistochemical Detection and Molecular Characterization of IDH-mutant Sinonasal Undifferentiated Carcinomas.
Mito JK; Bishop JA; Sadow PM; Stelow EB; Faquin WC; Mills SE; Krane JF; French CA; Fletcher CDM; Hornick JL; Sholl LM; Jo VY
Am J Surg Pathol; 2018 Aug; 42(8):1067-1075. PubMed ID: 29683816
[TBL] [Abstract][Full Text] [Related]
16. Comprehensive Molecular Profiling of Olfactory Neuroblastoma Identifies Potentially Targetable
Lazo de la Vega L; McHugh JB; Cani AK; Kunder K; Walocko FM; Liu CJ; Hovelson DH; Robinson D; Chinnaiyan AM; Tomlins SA; Harms PW
Mol Cancer Res; 2017 Nov; 15(11):1551-1557. PubMed ID: 28775129
[TBL] [Abstract][Full Text] [Related]
17. Assessing CpG island methylator phenotype, 1p/19q codeletion, and MGMT promoter methylation from epigenome-wide data in the biomarker cohort of the NOA-04 trial.
Wiestler B; Capper D; Hovestadt V; Sill M; Jones DT; Hartmann C; Felsberg J; Platten M; Feiden W; Keyvani K; Pfister SM; Wiestler OD; Meyermann R; Reifenberger G; Pietsch T; von Deimling A; Weller M; Wick W
Neuro Oncol; 2014 Dec; 16(12):1630-8. PubMed ID: 25028501
[TBL] [Abstract][Full Text] [Related]
18. Genetic profiling of poorly differentiated sinonasal tumours.
López-Hernández A; Vivanco B; Franchi A; Bloemena E; Cabal VN; Potes S; Riobello C; García-Inclán C; López F; Llorente JL; Hermsen M
Sci Rep; 2018 Mar; 8(1):3998. PubMed ID: 29507386
[TBL] [Abstract][Full Text] [Related]
19. Targeted 595-gene genomic profiling demonstrates low tumor mutational burden in olfactory neuroblastoma.
Friedman J; Schumacher JK; Papagiannopoulos P; Al-Khudari S; Tajudeen BA; Batra PS
Int Forum Allergy Rhinol; 2021 Jan; 11(1):58-64. PubMed ID: 32558242
[TBL] [Abstract][Full Text] [Related]
20. Identification of retinol binding protein 1 promoter hypermethylation in isocitrate dehydrogenase 1 and 2 mutant gliomas.
Chou AP; Chowdhury R; Li S; Chen W; Kim AJ; Piccioni DE; Selfridge JM; Mody RR; Chang S; Lalezari S; Lin J; Sanchez DE; Wilson RW; Garrett MC; Harry B; Mottahedeh J; Nghiemphu PL; Kornblum HI; Mischel PS; Prins RM; Yong WH; Cloughesy T; Nelson SF; Liau LM; Lai A
J Natl Cancer Inst; 2012 Oct; 104(19):1458-69. PubMed ID: 22945948
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
